CAPS Rating

CheapHessian (< 20)

Results 1 - 20 of 45 : 1 2 3 Next »
Top Pick Start Date Ticker CAPS Rating Call Time Frame Start Price Today (Change) Stock Gain Index Gain Score End Date Pitch
17/03/2014 TGD.US 2 out of 5 Outperform 5Y $1.70 $1.28 (-5.19%) -24.71% +0.43% -25.14
17/03/2014 FNV.US 3 out of 5 Outperform 5Y $52.43 $46.25 (-0.04%) -11.79% +0.43% -12.22
17/03/2014 LODE.US 1 out of 5 Outperform 5Y $1.94 $1.69 (+2.42%) -12.89% +0.43% -13.32
17/03/2014 GDXJ.US 3 out of 5 Outperform 5Y $44.33 $34.66 (-2.37%) -21.81% +0.43% -22.24
17/03/2014 AEM.US 3 out of 5 Outperform 5Y $34.37 $28.39 (+1.83%) -17.40% +0.43% -17.83
17/03/2014 ANV.US 2 out of 5 Outperform 5Y $6.37 $3.63 (+0.83%) -43.01% +0.43% -43.45
17/03/2014 GG.US 3 out of 5 Outperform 5Y $28.45 $23.60 (-0.88%) -17.05% +0.43% -17.48
29/02/2012 16/03/2014 AMZN.US 3 out of 5 Underperform 3Y $179.70 $324.91 (+0.38%) +80.81% +35.71% -45.09
26/02/2013 EXK.US 3 out of 5 Outperform 5Y $6.21 $4.14 (-2.82%) -33.33% +24.49% -57.83
11/02/2013 FSM.US 2 out of 5 Outperform 5Y $4.47 $3.78 (-3.08%) -15.44% +22.84% -38.27
11/02/2013 PAAS.US 3 out of 5 Outperform 5Y $16.77 $12.86 (-1.53%) -23.33% +22.84% -46.16
05/02/2013 RIC.US 3 out of 5 Outperform 5Y $3.20 $1.30 (-3.70%) -59.37% +23.97% -83.34
05/02/2013 AXU.US 2 out of 5 Outperform 5Y $4.58 $1.29 (-4.44%) -71.83% +23.97% -95.80
04/02/2013 SSRI.US 3 out of 5 Outperform 5Y $12.09 $9.60 (-2.24%) -20.60% +24.00% -44.59
04/02/2013 GORO.US 1 out of 5 Outperform 5Y $12.77 $4.60 (-3.56%) -63.97% +24.00% -87.97
24/01/2013 SGSVF.US 2 out of 5 Outperform 5Y $2.51 $0.65 (+0.18%) -74.12% +24.97% -99.09
23/01/2013 NRT.US 3 out of 5 Outperform 1Y $22.71 $23.85 (+0.51%) +5.04% +24.98% -19.95
23/01/2013 POT.US 4 out of 5 Outperform 5Y $39.68 $34.90 (-0.31%) -12.04% +24.98% -37.03
23/01/2013 CPE.US 2 out of 5 Outperform 5Y $5.22 $9.52 (+2.59%) +82.38% +24.98% +57.39
14/01/2013 IAG.US 3 out of 5 Outperform 5Y $10.58 $3.44 (-0.86%) -67.49% +26.89% -94.38
Results 1 - 20 of 45 : : 1 2 3 Next »

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.